RUN vs SER · P/E 6.0, rev $2.04B vs rev $56.0K
Sunrun Inc (RUN) versus Serina Therapeutics Inc (SER) — a side-by-side from cached financials, not a winner call.
Sunrun Inc (RUN) is a solar company listed on NASDAQ.
Serina Therapeutics Inc (SER) is a biotechnology company listed on AMEX.
Latest reported RUN revenue for 2024-12-31 was $2.04B. Net income was -$4.36B. Revenue was down 9.8% from 2023-12-31 to 2024-12-31. RUN currently screens at market cap $3.05B and trailing P/E 6.0.
Latest reported SER revenue for 2024-12-31 was $56.0K. Net income was -$11.2M. Revenue was down 98.2% from 2023-12-31 to 2024-12-31. SER currently screens at market cap $29.7M.
RUN currently screens at market cap $3.05B and trailing P/E 6.0. SER currently screens at market cap $29.7M.
Not investment advice. Open the RUN and SER stock pages for the full models.
Not investment advice.